ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DCPC Board Finally Approves Prescribe for Health Concept on 7-4 Vote, Okays RFA On Micronutrients

October 21, 1988

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

Social Networks Influence Decision To Quit Smoking

May 30, 2008

NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase

May 27, 1994

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006